세계의 미용 주사제 시장 : 제품별, 성별, 용도별, 최종 사용자별 - 예측(2025-2030년)

The Aesthetic Injectables Market was valued at USD 11.08 billion in 2023, expected to reach USD 11.95 billion in 2024, and is projected to grow at a CAGR of 7.85%, to USD 18.81 billion by 2030.

Aesthetic injectables, encompassing dermal fillers and botulinum toxins, aim to restore a youthful appearance and enhance facial features. These products address various aesthetic concerns, including wrinkle reduction, lip augmentation, and facial contouring. The growing desire for non-surgical and minimally invasive cosmetic treatments, fueled by advancements in product formulations and an increasing aging population seeking aesthetic improvements, underscores the necessity for aesthetic injectables. Application-wise, these can be administered to facial areas like the forehead, crow's feet, cheeks, lips, and jawline. The primary end-users include cosmetic clinics, dermatology centers, hospitals, and at times, dental practices. Market insights reveal key growth drivers such as rising disposable incomes, social media influence amplifying beauty trends, and heightened awareness of aesthetic treatment availability. Additionally, male consumer interest is growing, further expanding the market. However, limitations include potential side effects, a lack of trained professionals in certain regions, and the premium cost of treatments. Moreover, stringent regulatory frameworks pose significant challenges to market growth, especially regarding product approval and safety compliance. To leverage potential opportunities, companies should focus on innovation in product formulations ensuring enhanced durability and mimetic enhancement, alongside expanding product indications to encompass therapeutic uses. Research into biodegradable alternatives and personalized injectables could usher in a new era of targeted cosmetic therapies. Additionally, expanding geographic presence in emerging markets with increasing cosmetic spending could provide new business avenues. On the innovation front, AI-driven consultations can allow for personalized treatment plans, improving patient satisfaction. The aesthetic injectables market is dynamic and primarily driven by consumer sentiments and emerging beauty standards, necessitating continuous adaptation and innovation to maintain competitive advantage. Businesses should stay abreast of technological advances and regulatory changes to effectively capitalize on market opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Aesthetic Injectables Market

The Aesthetic Injectables Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising usage of aesthetic injections due to beauty trends and aging population
  • Increasing number of spa and beauty salons
  • Government and health authority reforms that promote aesthetic treatment options
• Market Restraints
  • High cost of aesthetic injectables and product recalls
• Market Opportunities
  • Ongoing innovations in the tools and methods used for administering aesthetic injectables
  • Venture capital investments into aesthetic injectable start-ups
• Market Challenges
  • Health risks associated with aesthetic injectables

Porter's Five Forces: A Strategic Tool for Navigating the Aesthetic Injectables Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Aesthetic Injectables Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Aesthetic Injectables Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Aesthetic Injectables Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Aesthetic Injectables Market

A detailed market share analysis in the Aesthetic Injectables Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Aesthetic Injectables Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Aesthetic Injectables Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Aesthetic Injectables Market

A strategic analysis of the Aesthetic Injectables Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Aesthetic Injectables Market, highlighting leading vendors and their innovative profiles. These include Adoderm GmbH, Allergan, Inc. by AbbVie Inc., Anika Therapeutics, Inc., Bio Plus Co., Ltd., Bioxis Pharmaceuticals, Bloomage Biotechnology Corp., Ltd., Bohus Biotech AB, Croma-Pharma GmbH, Cutera, Inc., Cynosure, LLC, Dr. Korman Laboratories Ltd., Galderma SA, Hugel America, Inc., Ipsen Pharma, Laboratoires Vivacy, S.A.S., MedyTox Inc., Merz Pharma GmbH & Co.KGaA, Prollenium Medical Technologies Inc., Revance Therapeutics, Inc., SciVision Biotech Inc., Sinclair Pharma Ltd, Suneva Medical, Inc., Teoxane SA, USWM, LLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Aesthetic Injectables Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Anti-aging Injections and Dermal Fillers. The Anti-aging Injections is further studied across Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Micro Particles. The Dermal Fillers is further studied across Collagen Fillers, Hyaluronic Acid, and Synthetic Fillers.
• Based on Gender, market is studied across Female and Male.
• Based on Application, market is studied across Acne Scar Treatment, Face Lift, Facial Line Correction, Lip Augmentation, and Lipoatrophy Treatment.
• Based on End User, market is studied across Beauty Clinics, Dermatology Clinics, Dermatology Research Institutes, and Medical Spa.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising usage of aesthetic injections due to beauty trends and aging population
    • 5.1.1.2. Increasing number of spa and beauty salons
    • 5.1.1.3. Government and health authority reforms that promote aesthetic treatment options
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of aesthetic injectables and product recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovations in the tools and methods used for administering aesthetic injectables
    • 5.1.3.2. Venture capital investments into aesthetic injectable start-ups
  • 5.1.4. Challenges
    • 5.1.4.1. Health risks associated with aesthetic injectables
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing usage of anti-aging injections to reduce the appearance of wrinkles
  • 5.2.2. End User: High accessibility of aesthetic injectables by dermatology clinics as they provide several cosmetic treatments
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Aesthetic Injectables Market, by Product

• 6.1. Introduction
• 6.2. Anti-aging Injections
  • 6.2.1. Botulinum Toxin A
  • 6.2.2. Poly-L-Lactic Acid (PLLA) Micro Particles
• 6.3. Dermal Fillers
  • 6.3.1. Collagen Fillers
  • 6.3.2. Hyaluronic Acid
  • 6.3.3. Synthetic Fillers

7. Aesthetic Injectables Market, by Gender

• 7.1. Introduction
• 7.2. Female
• 7.3. Male

8. Aesthetic Injectables Market, by Application

• 8.1. Introduction
• 8.2. Acne Scar Treatment
• 8.3. Face Lift
• 8.4. Facial Line Correction
• 8.5. Lip Augmentation
• 8.6. Lipoatrophy Treatment

9. Aesthetic Injectables Market, by End User

• 9.1. Introduction
• 9.2. Beauty Clinics
• 9.3. Dermatology Clinics
• 9.4. Dermatology Research Institutes
• 9.5. Medical Spa

10. Americas Aesthetic Injectables Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Aesthetic Injectables Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Aesthetic Injectables Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Cynosure and Lutronic Merge to Form Global Leader in Medical Aesthetic Technology
  • 13.3.2. Galderma Launches FACE by Galderma, a New AR Tool Helps Visualize Injectable Treatment Results
  • 13.3.3. FDA Approves SKINVIVE by JUVEDERM, a new U.S. Hyaluronic Acid Injection for Smoother Cheeks
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Adoderm GmbH
• 2. Allergan, Inc. by AbbVie Inc.
• 3. Anika Therapeutics, Inc.
• 4. Bio Plus Co., Ltd.
• 5. Bioxis Pharmaceuticals
• 6. Bloomage Biotechnology Corp., Ltd.
• 7. Bohus Biotech AB
• 8. Croma-Pharma GmbH
• 9. Cutera, Inc.
• 10. Cynosure, LLC
• 11. Dr. Korman Laboratories Ltd.
• 12. Galderma SA
• 13. Hugel America, Inc.
• 14. Ipsen Pharma
• 15. Laboratoires Vivacy, S.A.S.
• 16. MedyTox Inc.
• 17. Merz Pharma GmbH & Co.KGaA
• 18. Prollenium Medical Technologies Inc.
• 19. Revance Therapeutics, Inc.
• 20. SciVision Biotech Inc.
• 21. Sinclair Pharma Ltd
• 22. Suneva Medical, Inc.
• 23. Teoxane SA
• 24. USWM, LLC
• 25. Zimmer Biomet Holdings, Inc.